Description
Factory-Direct Master Case and Full-Pallet Supply
Brand: Conkote®
Product Type: Silver alginate wound dressing
Ordering Format: Master case or full pallet
Fulfillment: Factory-direct shipment
Pricing Basis: Per master case or per full pallet
Minimum Order Quantity: 1 master case
Product Overview
Conkote® Silver Alginate Dressing is an absorbent advanced wound dressing combining alginate fibers with ionic silver. It is designed to support the management of moderate-to-heavy wound exudate while helping maintain a cleaner wound environment.
When exposed to wound fluid, the alginate material forms a soft, moist gel that conforms to the wound bed and supports exudate management. The incorporated silver provides sustained antimicrobial activity as described in the manufacturer’s instructions for use.
Available in two clinical sizes and supplied exclusively through factory-direct master-case and full-pallet configurations for healthcare facilities, distributors, wound-care providers, institutional purchasers, and approved resellers.
Product Features
- High-absorbency alginate wound-contact material
- Ionic silver incorporated for antimicrobial wound management
- Designed for moderate-to-heavy exudate
- Soft and conformable dressing construction
- Supports a moist wound-management environment
- Available in two commonly requested dressing sizes
- Individually packaged dressings within each retail box
- Commercial packaging suitable for institutional distribution
- Factory-direct master-case and pallet fulfillment
- Lot-controlled inventory for professional supply channels
Variant 1: Conkote Silver Alginate Dressing — 4 × 4 in
Manufacturer REF: 214 001
Metric Size: Approximately 10 × 10 cm
Box Quantity: 5 dressings
Master Case: 80 boxes
Total per Master Case: 400 dressings
Master-Case Price
| Quantity | Boxes | Total Dressings | Selling Price |
|---|---|---|---|
| 1 Master Case | 80 | 400 | $13,465.60 |
Scaled Pallet Supply
| Supply Level | Master Cases | Total Boxes | Total Dressings | Selling Price |
|---|---|---|---|---|
| Half-Pallet Planning Quantity | 10 | 800 | 4,000 | $134,656.00 |
| Standard Pallet Planning Quantity | 20 | 1,600 | 8,000 | $269,312.00 |
| Two-Pallet Supply Lot | 40 | 3,200 | 16,000 | $538,624.00 |
Master-Case SKU: TWH-CONK-SA-214001-MC
Standard-Pallet SKU: TWH-CONK-SA-214001-PLT20
Variant 2: Conkote Silver Alginate Dressing — 2 × 2 in
Manufacturer REF: 214 002
Metric Size: Approximately 5 × 5 cm
Box Quantity: 10 dressings
Master Case: 80 boxes
Total per Master Case: 800 dressings
Master-Case Price
| Quantity | Boxes | Total Dressings | Selling Price |
|---|---|---|---|
| 1 Master Case | 80 | 800 | $13,465.60 |
Scaled Pallet Supply
| Supply Level | Master Cases | Total Boxes | Total Dressings | Selling Price |
|---|---|---|---|---|
| Half-Pallet Planning Quantity | 10 | 800 | 8,000 | $134,656.00 |
| Standard Pallet Planning Quantity | 20 | 1,600 | 16,000 | $269,312.00 |
| Two-Pallet Supply Lot | 40 | 3,200 | 32,000 | $538,624.00 |
Master-Case SKU: TWH-CONK-SA-214002-MC
Standard-Pallet SKU: TWH-CONK-SA-214002-PLT20
Product-Page Variant Options
Conkote Silver Alginate Dressing — 4 × 4 in
- Master Case: 80 boxes / 400 dressings — $13,465.60
- Half Pallet: 800 boxes / 4,000 dressings — $134,656.00
- Standard Pallet: 1,600 boxes / 8,000 dressings — $269,312.00
- Two-Pallet Lot: 3,200 boxes / 16,000 dressings — $538,624.00
Conkote Silver Alginate Dressing — 2 × 2 in
- Master Case: 80 boxes / 800 dressings — $13,465.60
- Half Pallet: 800 boxes / 8,000 dressings — $134,656.00
- Standard Pallet: 1,600 boxes / 16,000 dressings — $269,312.00
- Two-Pallet Lot: 3,200 boxes / 32,000 dressings — $538,624.00
Intended Applications
Conkote Silver Alginate Dressing may be selected by qualified healthcare professionals for wounds requiring absorbent wound-management support, subject to the product’s authorized indications and instructions for use.
Potential professional-use settings include:
- Wound-care clinics
- Hospitals and surgical centers
- Long-term care facilities
- Home-health agencies
- Outpatient treatment centers
- Institutional medical-supply programs
- Government and commercial healthcare procurement
Factory-Direct Shipping Terms
This product is offered as a factory-direct commercial shipment rather than as an individual retail-box purchase.
- Orders must be placed in complete master-case or full-pallet quantities.
- Master cases may not be divided for factory-direct fulfillment.
- Full-pallet case counts depend on the manufacturer’s current carton dimensions and export-packing configuration.
- Shipping charges are calculated separately based on destination, quantity, delivery requirements, and freight service.
- International orders may be subject to customs duties, taxes, brokerage charges, and import-documentation requirements.
- Production lot, shelf life, carton dimensions, gross weight, lead time, and pallet configuration should be confirmed on the final quotation or pro forma invoice.
Storage and Handling
Store the product in its original packaging under the temperature, humidity, and environmental conditions stated by the manufacturer. Protect cartons from moisture, contamination, crushing, direct sunlight, and excessive heat.
Do not use a dressing when its individual package is open, damaged, contaminated, or beyond the marked expiration date. Follow the product labeling and manufacturer’s instructions for use.
Professional-Use Notice
This listing is intended for commercial procurement and product-identification purposes. Product selection, wound assessment, application frequency, dressing changes, and discontinuation should be determined by a qualified healthcare professional.
The dressing should be used only for its authorized intended purpose and in accordance with the manufacturer’s current labeling and instructions. Product images and illustrations are representative and may not reflect the precise packaging supplied for every production lot or destination market.
FDA REGULATORY STATUS
Manufacturer:
Hongyu Biotech (Shenzhen) Co., Ltd.
FDA FEI / Establishment Registration No.:
3017107376
Current Registration Year:
2026
FDA Device Listing:
Silver Alginate Dressing
FDA Classification Name:
Dressing, Wound, Drug
FDA Product Code:
FRO
Premarket Review Pathway:
510(k) Premarket Notification
Establishment Operations:
Contract Manufacturer / Foreign Exporter
The manufacturer is registered with the U.S. Food and Drug Administration and
lists Silver Alginate Dressing within the FDA Establishment Registration &
Device Listing database under product code FRO.
The manufacturer has represented that its Silver Alginate Dressing is covered
by 510(k) clearance. FDA registration and device listing do not constitute FDA
approval or endorsement. The exact 510(k) number, cleared device name,
indications for use, and covered model or reference numbers should be verified
against the applicable FDA substantial-equivalence order before a specific
K-number is published.
FDA 510(k) PREMARKET NOTIFICATION NOTICE
Silver Alginate Dressing is regulated under FDA product code FRO, classification
name “Dressing, Wound, Drug,” and is subject to the 510(k) premarket notification
pathway.
A 510(k) clearance means FDA determined that the cleared device was substantially
equivalent to a legally marketed predicate device. The correct terminology is
“FDA cleared,” not “FDA approved.”
Any FDA-clearance representation applies only to the device name, intended use,
materials, configurations, sizes, labeling, and reference numbers expressly
covered by the applicable 510(k) record. No expanded indication or clinical claim
is intended beyond the manufacturer’s cleared labeling and instructions for use.
Labeling and Intended-Use Limitation
The product may be advertised, distributed, and used only within the indications, patient population, wound types, duration of use, contraindications, warnings, and application instructions contained in the manufacturer’s current authorized labeling and instructions for use.
Claims such as “treats infection,” “prevents infection,” “accelerates healing,” “kills specific organisms,” or “provides protection for a stated number of days” should not be published unless those exact claims are supported by the cleared labeling and manufacturer documentation. FDA evaluates a device’s intended use based substantially on its proposed labeling and accompanying promotional materials.